Postpartum thyroiditis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
|||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as [[Postpartum thyroiditis primary prevention|primary preventive measures]]. Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases. | |||
Effective measures for the secondary prevention of [[ | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Effective measures for the secondary prevention of [[ | *Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as its [[Postpartum thyroiditis primary prevention|primary preventive measures]]. <ref name="pmid17284630">{{cite journal| author=Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H| title=The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. | journal=J Clin Endocrinol Metab | year= 2007 | volume= 92 | issue= 4 | pages= 1263-8 | pmid=17284630 | doi=10.1210/jc.2006-1821 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17284630 }}</ref> | ||
*Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of postpartum thyroiditis cases.<ref name="pmid20614463">{{cite journal| author=Reid SM, Middleton P, Cossich MC, Crowther CA| title=Interventions for clinical and subclinical hypothyroidism in pregnancy. | journal=Cochrane Database Syst Rev | year= 2010 | volume= | issue= 7 | pages= CD007752 | pmid=20614463 | doi=10.1002/14651858.CD007752.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20614463 }}</ref> | *Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases.<ref name="pmid20614463">{{cite journal| author=Reid SM, Middleton P, Cossich MC, Crowther CA| title=Interventions for clinical and subclinical hypothyroidism in pregnancy. | journal=Cochrane Database Syst Rev | year= 2010 | volume= | issue= 7 | pages= CD007752 | pmid=20614463 | doi=10.1002/14651858.CD007752.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20614463 }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 17:45, 15 November 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis secondary prevention |
|
Risk calculators and risk factors for Postpartum thyroiditis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
Effective measures for the secondary prevention of postpartum thyroiditis are same as primary preventive measures. Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of postpartum thyroiditis cases.
Secondary Prevention
- Effective measures for the secondary prevention of postpartum thyroiditis are same as its primary preventive measures. [1]
- Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of postpartum thyroiditis cases.[2]
References
- ↑ Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2007). "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies". J Clin Endocrinol Metab. 92 (4): 1263–8. doi:10.1210/jc.2006-1821. PMID 17284630.
- ↑ Reid SM, Middleton P, Cossich MC, Crowther CA (2010). "Interventions for clinical and subclinical hypothyroidism in pregnancy". Cochrane Database Syst Rev (7): CD007752. doi:10.1002/14651858.CD007752.pub2. PMID 20614463.